Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT02253602
Eligibility Criteria:
Inclusion Criteria:
* Patients with biopsy proven esophageal cancer (squamous cell carcinoma or adenocarcinoma)
* Suspected nodal involvement on EUS or CT at diagnosis.
* WHO-performance score 0-2
* Scheduled for surgery
* Written informed consent
Exclusion Criteria:
* Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol
* Contra-indications for MR scanning, including patients with a pacemaker, cochlear implant or neurostimulator; patients with non-MR compatible metallic implants in their eye, spine, thorax or abdomen; or a non-MR compatible aneurysm clip in their brain; patients with severe claustrophobia
* Active inflammatory diseases
* History of anaphylaxis or other hypersensitivity reactions
* History of iron overload
* History of abnormal liver function, or elevated liver enzymes (ALAT, ASAT \> 3 times upper limit of normal)
* Elevated Serum Transferrin Saturation (TSAT) (\>50%) or hemoglobin (\>10.5mmol/L)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02253602
Study Brief:
Protocol Section:
NCT02253602